Although its role in cancer is unclear, GPCR signaling has been widely recognized for its involvement in tumor proliferation and metastasis (Lappano and Maggiolini, 2012), suggesting GPRASP2 may participate in oncogenic pathways via m6A-related post-transcriptional regulation. The gene discussed is GPRASP2; the disease is cancer.